• Patients with hypokalemia & electrolyte abnormalities

• Inherited tubulopathies (Gitelman, Bartter, etc.)

• ER patients with thyrotoxic hypokalemic paralysis

• Chronic hypokalemia follow-up cases

• Recurrent undiagnosed hypokalemia patients

• Domestic/intl nephrology trainees

Tri-Service General Hospital's Nephrology built the "World Innovation Hypokalemia Team," integrating nephrologists, ER, nursing, genetics lab, and transgenic mouse platform. Traditional hypokalemia diagnosis requires 24-hour urine collection, weeks-months, and repeated invasive blood draws; this team's "spot urine biochemistry rapid analysis" diagnoses etiology within 60 minutes, preventing rebound hyperkalemia and worsening paralysis. For Taiwan's common inherited Gitelman syndrome (SLC12A3 mutation, carrier rate 1-4%), the world-first 22-hotspot screening panel produces genotypes in 4 hours. Multiple transgenic mouse models established: NCC (Gitelman), NBC (renal tubular acidosis), KLHL3 (pseudohypoaldosteronism), Maged2 (X-linked Bartter). Dr. Chin Lin's team developed an AI-EKG (CNN) model that non-invasively predicts serum potassium in 10 seconds, with AUROC surpassing Mayo Clinic and others. The team leads worldwide in hypokalemia publications (91 papers, 3,043 total citations, 33.44 avg/paper); spot urine biochemistry is now in textbooks and global guidelines. Featured on Discovery "Taiwan's Amazing" series; invited to 2022 World Congress of Nephrology.

• Spot urine biochem diagnosis in 60 min

• World-first 22-hotspot Gitelman panel

• Genotyping in 4 hours

• AI-EKG CNN potassium prediction (10 sec, noninvasive)

• 5 transgenic mouse models of tubulopathies

• Global guidelines adopt our diagnostic flow

• 91 hypokalemia papers (world #1)

• 3,043 total citations

• Avg 33.44 citations/paper

• AI-EKG trained on 40,180 patients

• Supported domestic genetics labs

• 2022 World Congress of Nephrology speaker

• AI-EKG high-K specificity 96%, NPV 98.5%

• Low-K specificity 81.6%, NPV 85.0%

• Outperforms Wu/Tzeng/Galloway prior studies

• Gitelman panel done in 4 hours

• Spot urine K/Na/Cl differential diagnosis

• Npj Digital Med (IF 11.665) accepted

• Faster diagnosis prevents treatment errors

• Reduces rebound hyperkalemia risk

• Reduces invasive blood draws

• Non-invasive AI-EKG arrhythmia monitoring

• Precision personalized treatment standard

• Genetics-therapy roadmap for tubulopathies

• Non-invasive rapid screening of hyperkalemia

• Physicians endorse AI-EKG assistance

• High patient satisfaction with precision dx

• Discovery "Amazing Taiwan" feature

• Media praise & wide outreach

• Hospital-wide adoption; spread to other hospitals

• 91 hypokalemia papers (world #1)

• NPJ Genom Med (Gitelman panel)

• Npj Digital Med (IF 11.665) AI-EKG

• Human Mutation/JASN/FASEB/NEJM journals

• Invited speaker, 2022 World Congress of Nephrology

• Russia Science Foundation collaboration

• Spot urine flow now in global guidelines

• Adopted by multiple domestic medical centers

• Advanced training for domestic nephrologists

• Toward gene therapy for precision medicine

• Established NGS for kidney multi-gene tests

• Discovery Channel feature recognition